Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

http://www.wikidata.org/entity/Q35986336

about

Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective Characterizing blood-brain barrier perturbations after exposure to human triglyceride-rich lipoprotein lipolysis products using MRI in a rat model.Brain imaging of neurovascular dysfunction in Alzheimer's disease.LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease.Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.Blood-brain barrier breakdown in the aging human hippocampus Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.Ratio of apoB/LDL: a potential clinical index for vascular cognitive impairment Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.Retracted: Advances in the physiological and pathological implications of cholesterol.Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link.MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.The current state of biomarkers of mild traumatic brain injury.Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.Focused ultrasound as a novel strategy for Alzheimer disease therapeutics.Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease.Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice

P2860

Q24316276-CBB395FB-3C4D-42E0-836A-25B96CAC3F61 Q26852369-DD4FF04E-E3E0-4F8E-A5D3-2C3F04D9D3E3 Q28067402-637C074D-16DC-402A-A532-64FCC09A577F Q30488441-28B90F8F-81C5-409E-B297-25D165553953 Q31066988-324362C0-6BBB-4CD9-ABDC-A4702957D66D Q33846928-189C8F5D-F69D-47BA-8D54-38915088EB90 Q33965410-38B96E4F-3DB2-40C4-B0A7-D4C3209AF180 Q35151019-358F24C7-1335-46E3-8E81-25088A048CD6 Q36093231-B955F776-37BA-4C0A-BBC2-AA64B2910B39 Q36204147-9845B583-04DA-489E-9E42-4F95B42EE02F Q36593210-DD4AA0BC-3CBF-45D9-B650-87AFF52E92B7 Q36767796-9302557D-A050-4CF6-8B34-B5682F8E7B6C Q36958137-FA82C5BE-DB89-4196-94F8-B8E5AB9176D7 Q38672178-86CD8AD4-0C38-4424-8E84-31DA55D9B526 Q38810704-C22096B3-5578-4CE4-8E44-79C14B39B4A5 Q38920531-9AE8859B-DC13-43E9-A2F9-59E0476CC385 Q46069993-6124787D-B993-4C19-85D4-6B439B01A23A Q47106839-76A671E2-B1C1-4F1E-B51E-9510678AD0A8 Q47650466-232C82D3-E7E1-4354-8A52-20D2BBC0C5E3 Q47658921-619704FD-1F87-4183-BB2D-5373A167B21D Q47707801-E93F8621-77CD-4C88-8685-0D2E67C191DF Q50239472-FE34B49B-F254-41B1-A7BB-070E603FE90D Q52717313-6931D306-A1BB-4EAE-8D76-E484D08468C5 Q58556081-B46FC8A7-956E-40D5-9E77-483689DF4A17

P2860

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

http://www.wikidata.org/entity/Q35986336

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@ast

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@en

type

label

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@ast

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@en

prefLabel

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@ast

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@en

P1433

Q35986336-E4EB3839-4836-4D15-99E1-F793DB2D74B1

P1476

Q35986336-6C6802EA-51F9-4C4B-B651-6555A7ED417E

P2093

Q35986336-2C803BEA-6BA5-4EAF-924C-F6909BC9D6A5

Q35986336-986A80A0-0371-488A-9155-E4328319204C

P2860

Q35986336-019FF228-8352-4D92-9F32-EBA00649F026

Q35986336-031E8E46-3B0D-4801-92B7-7FF35439A668

Q35986336-20E10B59-9825-4B69-9771-52AB1DB04ADA

Q35986336-25438322-9834-4E02-B3F6-F0B78BEE3C0B

Q35986336-3CC6B2BA-FB44-44BF-8370-4D328683FAFF

Q35986336-4C971238-B4D4-400E-8F68-7063D5556E3B

Q35986336-71585ACF-ED44-4AA9-A96B-C305EDEED142

Q35986336-7DB69A42-335A-406F-9697-4D3A9D2BE0E2

Q35986336-8A903B00-B9F1-49D1-BBD5-90743E030795

Q35986336-ADDFF9B1-5A26-4061-B03F-C280E8E7CC3E

P304

Q35986336-8BD8B11A-6B29-452D-8325-52F202CFCF32

P31

Q35986336-0DD98411-04B8-45AB-8DBE-D85955439938

P356

Q35986336-5F743F56-BE54-4A22-A44F-B7E7C82083C4

P478

Q35986336-87577411-41D9-4F52-A1B4-FD2D65710C6A

P50

Q35986336-E4FCD055-CB9D-48AD-9885-4D429C9FCA29

P577

Q35986336-84C01F3A-B7A6-4F7C-A2D5-25CC55E69BD3

P5875

Q35986336-805ADFCB-8E08-4B78-9540-497E983628BF

P698

Q35986336-8245CF17-B610-4469-8F32-297256508071

P921

Q35986336-0500034A-EDB2-4C23-A1C8-F0501997AD80

Q35986336-47C3AB01-4887-444C-B327-409839A3E9D3

Q35986336-573A97FA-1C6E-47E6-A18F-05C5506B9674

P932

Q35986336-C0B42F2A-26A1-4521-9411-294E307A573E

P356

P1433

Current gerontology and geriatrics research

P1476

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

@en

P2093

Gene L Bowman

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Kaye

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Development and validation of a geriatric depression screening scale: a preliminary report

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

Structural and functional aspects of the blood-brain barrier.

Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study

P304

184042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/184042

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225087105

http://www.w3.org/2001/XMLSchema#string

P698

22654903

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

blood–brain barrier

P932

3359662

http://www.w3.org/2001/XMLSchema#string